Get started
Author

Alper Tuna Güven

Observed names: AT Güven, Alper Güven, Alper T. Güven, Alper Tuna Guven, Alper Tuna GÜVEN, GÜVEN, ALPER TUNA, Güven, Alper Tuna
ORCID: 0000-0002-6310-4240
Observed ORCID: 0000-0002-6310-4240
OpenAlex ID: A5001330349
Evaluation of renal fibrosis in various causes of glomerulonephritis by MR elastography: a clinicopathologic comparative analysis
2021 · Alper Tuna Güven, Ilkay S. Idilman, et al. · Abdominal Radiology · 23
Evaluation of machine learning algorithms for renin-angiotensin-aldosterone system inhibitors associated renal adverse event prediction
2023 · Alper Tuna Güven, Murat Özdede, et al. · European Journal of Internal Medicine · 17
PDF
Obesity-Related Disorders in Türkiye: A Multi Center, Retrospective, Cross-Sectional Analysis from the OBREDI-TR Study
2025 · Alihan Oral, Ihsan Solmaz, et al. · Journal of Clinical Medicine · 11
PDF
Effects of Smoking on Hematological Parameters and Ferritin Levels
2019 · Rafiye Çiftçiler, Alper Güven, et al. · Medical Bulletin of Haseki · 11
PDF
Quality gap in venous thromboembolism prophylaxis practices in inpatients: Assessment of prophylaxis practices in a University Hospital
2021 · Alper Tuna Güven, Sabri Engin Altintop, et al. · International Journal for Quality in Health Care · 7
Weight Misperception is Prevalent Among Turkish Adults and Associated with Higher Age, Body Mass Index and Lower Education Status
2024 · Alper Güven, Murat Özdede, et al. · Diabetes Metabolic Syndrome and Obesity · 5
Reliability and validity of the Turkish version of the Self-care of Hypertension Inventory Version 3.0 in adults with hypertension
2024 · Beyza Nur Durukan, Yusuf Ziya Sener, et al. · Journal of Vascular Nursing · 4
Machine Learning Insights Into Uric Acid Elevation With Thiazide Therapy Commencement and Intensification
2023 · Murat Özdede, Alper Tuna Güven, et al. · Cureus · 4
PDF
Drug-Associated Thrombocytopenia as a Rare and Devastating Side Effect of Octreotide in a Cirrhotic Patients: A Case Report and Current Literature Review
2021 · Sabri Engin Altintop, Alper Tuna Guven, et al. · Medical Bulletin of Haseki · 4
PDF
Predictors of mortality, mortality rates, and clinical characteristics of adult patients with extreme hyperferritinemia
2024 · Alper Tuna Güven, Naciye Hocanın, et al. · Irish Journal of Medical Science (1971 -) · 3
Discordance Between FIB-4 and BAST Fibrosis Risk Classifications in Obese Patients with MASLD: Results from the OBREDI-TR Study
2026 · Ozge Kama Basci, Alihan Oral, et al. · Diagnostics · 2
PDF
Systemic Immune Inflammation Index and Neutrophil-to-Lymphocyte Ratio Correlate with Fasting Glucose Levels Among Type 2 Diabetic Patients
2024 · Alper Tuna Güven · European Journal of Therapeutics · 2
PDF
Angiotensin converting enzyme inhibitors related cough and associated medications
2024 · Alper Tuna GÜVEN, Murat ÖZDEDE · DAHUDER Medical Journal · 2
PDF
Evaluation of the Relationship between Inflammatory, Metabolic, and Liver-Related Indexes and Blood Pressure Dipping Ratios: A Retrospective Study
2023 · AT Güven · Nigerian Journal of Clinical Practice · 2
Psoriatic Inflammation-Induced Atypically Located Venous Thromboembolism: A Case of Immuno-Thrombosis
2023 · AT Güven, YZ Şener, et al. · Nigerian Journal of Clinical Practice · 2
Systemic bacillus Calmette-Guérin (BCG) infection and accompanying warm autoimmune haemolytic anaemia following intravesical BCG immunotherapy
2023 · Alper Tuna Güven, Yusuf Ziya Demiroğlu, et al. · European Journal of Case Reports in Internal Medicine · 2
PDF
Diyabet ve Kardiyovasküler Hastalıklar
2023 · İhsan Ayhan, Ari Avni Erbil, et al. · Akademisyen Kitabevi eBooks · 2
PDF
The Collateral Benefit of COVID Pandemic: Improved Pharmacological Venous Thromboembolism Prophylaxis Practices in Non-COVID Patients
2023 · Murat Özdede, Alper Tuna Güven, et al. · International Journal of General Medicine · 2
PDF
Rapidly Occurring Statin-Associated Muscle Symptoms With Rosuvastatin
2022 · Alper Tuna Güven · American Journal of Therapeutics · 2
Finerenone Use in Heart Failure Patients with Type 2 Diabetes and Kidney Disease: An Analysis of the FINE-TURK Registry
2026 · Serap Yadigar, Suat Akgür, et al. · Cardiovascular Drugs and Therapy · 1
PDF
Early laboratory trajectories and short-term tolerability after finerenone initiationin diabetic kidney disease: the multicenter FINE-TURK study
2026 · Serap Yadigar, Suat Akgür, et al. · BMC Nephrology · 1
Hyperkalemia risk with finerenone in diabetic kidney disease: a real-world analysis from the FINE-TURK cohort
2026 · Murat Özdede, Serap Yadigar, et al. · Clinical Kidney Journal · 1
Factors Associated with Ferric Carboxymaltose‑Related Clinically Significant Hypophosphatemia: A Single-Center Retrospective Cohort Study
2026 · Yusuf Kimyon, Duygu Abdurakhmanov, et al. · Indian Journal of Hematology and Blood Transfusion · 1
An Assessment of Cardiovascular Health Risks in People Working from Home During the Pandemic Period: PANDEV-KALP Study
2026 · Gökhan Tazegül, Volkan Aydın, et al. · DAHUDER Medical Journal · 1
PDF
An Extremely Rare Case of Gastroptosis Treated Successfully with Itopride in a Patient with Parkinson’s Disease
2025 · Kübra Yildiz Cömert, Alper Tuna Güven · Nigerian Postgraduate Medical Journal · 1
Works count: 61
Citation count: 120
H-index: 5
I10-index: 4
Year
Topic
Type